Skip to main content
. 2021 Sep 29;8:722154. doi: 10.3389/fcvm.2021.722154

Table 1.

Mendelian randomization estimates between self-reported physical activity and cardiovascular diseases.

Exposure Self-reported moderate-to-vigorous physical activity Self-reported vigorous physical activity
Outcomes Method OR 95% CI p-value SNPs Method OR 95% CI p-value SNPs
Atrial fibrillation IVW 1.13 0.79–1.6 0.508 9 IVW§ 1.33 0.44–4.05 0.615 5
MR-Egger 0.41 0.08–1.99 0.268 9 MR-Egger 0.00 0–13.36 0.177 5
Weighted median 1.16 0.72–1.86 0.546 9 Weighted median 1.51 0.51–4.48 0.457 5
MR-PRESSO 1.13 0.82–1.55 0.493 9 MR-PRESSO 1.33 0.44–4.05 0.641 5
Coronary artery disease IVW 1.21 0.72–2.01 0.469 7, IVW 0.50 0.19–1.26 0.141 5
MR-Egger 0.72 0.09–5.43 0.747 7, MR-Egger 0.55 0.18–1.73 0.308 5
Weighted median 1.05 0.55–1.99 0.880 7, Weighted median 0.55 0.18–1.73 0.308 5
MR-PRESSO 1.21 0.85–1.71 0.326 7, MR-PRESSO 0.50 0.27–0.9 0.084 5
Myocardial infarction IVW 1.48 0.84–2.61 0.178 7, IVW 0.24 0.08–0.68 0.007 5
MR-Egger 0.54 0–150.86 0.829 7, MR-Egger 0.04 0–271.79 0.467 5
Weighted median 0.86 0.15–4.85 0.869 7, Weighted median 0.22 0.06–0.78 0.019 5
MR-PRESSO 1.48 0.93–2.35 0.151 7, MR-PRESSO 0.24 0.12–0.47 0.014 5
Heart failure IVW 0.89 0.6–1.31 0.543 9 IVW 1.57 0.71–3.45 0.263 5
MR-Egger 0.47 0.09–2.38 0.360 9 MR-Egger 0.00 0.00–0.25 0.017 5
Weighted median 1.10 0.64–1.87 0.738 9 Weighted median 2.24 0.74–6.77 0.151 5
MR-PRESSO 0.89 0.62–1.27 0.532 9 MR-PRESSO 1.57 0.51–4.78 0.473 5
Ischemic stroke IVW 1.14 0.69–1.89 0.606 8 IVW 0.97 0.36–2.65 0.955 5
MR-Egger 0.61 0.08–4.42 0.622 8 MR-Egger 0.09 0.00–375.81 0.565 5
Weighted median 1.01 0.54–1.9 0.977 8 Weighted median 0.79 0.23–2.78 0.718 5
MR-PRESSO 1.14 0.79–1.66 0.509 8 MR-PRESSO 0.97 0.45–2.09 0.945 5
Large artery stroke IVW 0.59 0.17–2.01 0.395 8 IVW 4.47 0.37–54.03 0.238 5
MR-Egger 0.07 0–34.44 0.396 8 MR-Egger 32.94 0.00–10∧15 0.827 5
Weighted median 0.47 0.09–2.51 0.374 8 Weighted median 1.45 0.04–55.54 0.841 5
MR-PRESSO 0.59 0.12–2.79 0.523 8 MR-PRESSO 4.47 0.18–113.99 0.416 5
Cardioembolic stroke IVW 1.68 0.64–4.41 0.289 8 IVW 1.06 0.16–7.05 0.956 5
MR-Egger 7.30 0.1–531.9 0.363 8 MR-Egger 0.00 0.00–61073.42 0.372 5
Weighted median 1.97 0.54–7.19 0.303 8 Weighted median 0.53 0.05–5.94 0.605 5
MR-PRESSO 1.68 0.58–4.92 0.373 8 MR-PRESSO 1.06 0.1–10.86 0.966 5
Small vessel stroke IVW 0.95 0.3–3.01 0.929 8 IVW 4.16 0.41–42.13 0.228 5
MR-Egger 0.60 0.01–60.23 0.828 8 MR-Egger 0.00 0.00–18910.03 0.333 5
Weighted median 0.85 0.19–3.87 0.832 8 Weighted median 1.85 0.09–37.68 0.690 5
MR-PRESSO 0.95 0.32–2.82 0.927 8 MR-PRESSO 4.16 0.51–33.61 0.252 5

OR, odds ratio; CI confidence intervals; IVW, inverse-variance-weighted method; MR-PRESSO, MR pleiotropy residual sum and outlier method; SNPs, single-nucleotide polymorphisms.

§

The estimates were evaluated from a random-effects IVW method due to the presence of heterogeneity based on Cochran's Q.

rs3094622 was excluded because it was unavailable in the published GWASs and no good proxies (r2 > 0.8) were found.

rs429358 was excluded since it as associated with coronary artery disease in the PhenoScanner database.